Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Immunoglobulin Domains
Pripstein, Jeremy
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Anorectal Malformations
Enzymatic disease of the podocyte.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Enzymatic disease of the podocyte.
Enzymatic disease of the podocyte. Pediatr Nephrol. 2010 Jun; 25(6):1017-23.
View in:
PubMed
subject areas
Animals
Cathepsin L
Humans
Kidney Diseases
Podocytes